{"nct_id":"NCT06841354","title":"A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-03-16","start_date_type":"ACTUAL","primary_completion_date":"2030-05-18","primary_completion_date_type":"ESTIMATED","completion_date":"2030-05-18","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}